Stock Comparison

INSM vs REGN

Insmed Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

INSM

Insmed Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$26.84B

$80.55B

P/E (TTM)

—

19.4

Forward P/E

15.4

17.1

Price/Sales

23.6

5.2

Price/Book

35.4

2.5

EV/EBITDA

-5.7

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

-144.44%

29.65%

Operating Margin

-137.74%

24.32%

Return on Equity

-87.20%

14.00%

Return on Assets

-22.20%

6.53%

Growth (YoY)

Revenue Growth

296.10%

16.70%

Earnings Growth

0.00%

-4.50%

Price & Risk

Beta

0.8

0.2

52-Week High

$211.41

$810.12

52-Week Low

$91.88

$553.38

Analyst Target

$197.82

$833.54

Compare INSM and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.